miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway

Author:

Isobe Taichi1,Hisamori Shigeo1,Hogan Daniel J2,Zabala Maider1,Hendrickson David G3,Dalerba Piero14,Cai Shang1,Scheeren Ferenc1,Kuo Angera H1,Sikandar Shaheen S1,Lam Jessica S1,Qian Dalong1,Dirbas Frederick M5,Somlo George6,Lao Kaiqin7,Brown Patrick O2,Clarke Michael F1,Shimono Yohei1

Affiliation:

1. Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, United States

2. Department of Biochemistry, Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, United States

3. Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, United States

4. Department of Medicine, Division of Oncology, Stanford University, Stanford, United States

5. Department of Surgery, Stanford University School of Medicine, Stanford, United States

6. City of Hope Cancer Center, Duarte, United States

7. Applied Biosystems, Foster City, United States

Abstract

MicroRNAs (miRNAs) are important regulators of stem and progenitor cell functions. We previously reported that miR-142 and miR-150 are upregulated in human breast cancer stem cells (BCSCs) as compared to the non-tumorigenic breast cancer cells. In this study, we report that miR-142 efficiently recruits the APC mRNA to an RNA-induced silencing complex, activates the canonical WNT signaling pathway in an APC-suppression dependent manner, and activates the expression of miR-150. Enforced expression of miR-142 or miR-150 in normal mouse mammary stem cells resulted in the regeneration of hyperproliferative mammary glands in vivo. Knockdown of endogenous miR-142 effectively suppressed organoid formation by BCSCs and slowed tumor growth initiated by human BCSCs in vivo. These results suggest that in some tumors, miR-142 regulates the properties of BCSCs at least in part by activating the WNT signaling pathway and miR-150 expression.

Funder

California Breast Cancer Research Program

Japan Society for the Promotion of Science

Fundación Alfonso Martín Escudero

Fulbright Commission

Research Foundation for Community Medicine, Japan

National Institutes of Health

Breast Cancer Research Foundation

Morton Family Foundation

Virginia and D.K. Ludwig Fund for Cancer Research

U.S. Department of Defense

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Cited by 154 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3